BioSpace News Archive

Business

Let’s Get to Know Paula Ragan, CEO and President of X4 Pharmaceuticals

BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.

April 21, 2021
·
4 min read
·
Gina Hagler
Genetown

Beam’s New CRISPR Base Editing Tool Targets Sickle Cell Mutation

Beam Therapeutics has recently unveiled a new CRISPR base editing tool to target sickle cell mutations, a promising approach that holds substantial clinical value for patients with these blood disorders.

April 21, 2021
·
3 min read
·
Brandon May
Global Roundup: Phico Therapeutics Wins CARB-X Funding for Bacteriophage Drug

Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.

April 21, 2021
·
5 min read
·
Alex Keown
Biotech Bay

Mission Bio Launches Assay Development Service for Single Cell Multiomics

Mission Bio just launched its Pharma Assay Development (PAD) service, enabling its customers to obtain early access services based on the newest technologies as well as on its existing products.

April 21, 2021
·
4 min read
·
Gail Dutton
Drug Development

Clearing Up a Misconception: COVID-19 Vaccines Don’t Cause Shingles

A small study by researchers in Israel published in the journal Rheumatology identified six cases of patients developing herpes zoster rashes (shingles) after receiving the Pfizer-BioNTech vaccine.

April 21, 2021
·
3 min read
·
Mark Terry
Drug Development

AAN Annual Meeting Highlights: Sleep Quality, Migraine, COVID-19 Interferon Treatment and More

The American Academy of Neurology Virtual Annual Meeting 2021 is ongoing from April 17 through 22, with literally hundreds of presentations. Here’s a peek at just some of them.

April 21, 2021
·
4 min read
·
Mark Terry
Policy

FDA Asks Emergent to Temporarily Halt J&J COVID-19 Vaccine Ingredient Production

The U.S. FDA has requested that Emergent BioSolutions temporarily pause production of ingredients for the Johnson & Johnson COVID-19 vaccine at their facility in Baltimore.

April 21, 2021
·
5 min read
·
Mark Terry
Versant Raises $560 Million For New Early-Stage Biotech Fund

The fund will seek to invest in at least 20 startups located in the U.S., Canada, and Europe.

April 21, 2021
·
2 min read
·
Mark Zipkin
Policy

Nearly $1.3 Billion in OWS Funds Went to ApjJect Systems for Syringes Yet to Be Authorized

ApiJect’s syringe is designed to be prefilled with a dose of a vaccine before it is shipped out to be used by doctors, pharmacists, hospitals, and many of the vaccination centers set up across the country. NBC noted that the prefilled technology had not been approved in the U.S.

April 21, 2021
·
2 min read
·
Alex Keown
Policy

Researchers Get to Work on Opioid Overuse Vaccine With $25 Million NIH Grant

A $25 million grant from the National Institutes of Health Helping to End Addiction Long-term Initiative (HEAL) is funding new research to develop a vaccine that may help patients overcome their addiction to opioids, a class of highly addictive pain medications.

April 21, 2021
·
2 min read
·
Brandon May